학술논문
Phase 1 study of intraventricular 131 I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Document Type
Article
Author
Source
In: Journal of Hematology and Oncology . (Journal of Hematology and Oncology, December 2022, 15(1))
Subject
Language
English
ISSN
17568722